SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-24-001345
Filing Date
2024-02-14
Accepted
2024-02-14 12:43:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 d10943920_13g-a.htm SC 13G/A 104661
  Complete submission text file 0000919574-24-001345.txt   106443
Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Subject) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79364 | Film No.: 24635115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20 MARSHALL STREET SUITE 310 SOUTH NORWALK CT 06854
Business Address 20 MARSHALL STREET SUITE 310 SOUTH NORWALK CT 06854 203-956-7953
DISCOVERY CAPITAL MANAGEMENT, LLC / CT (Filed by) CIK: 0001389507 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CT
Type: SC 13G/A